...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Article

This article pretty well maps out BOM2:

Apabetalone decreased the risk of major cardiovascular events (MACE) and hospitalization for congestive heart failure compared with placebo among patients with diabetic CKD and recent acute coronary syndrome.

Giddy Up Don!

 

Koo

 

Share
New Message
Please login to post a reply